Basic information
- CAS
41862-09-3- Standard SMILES
CCn1c(N)cc(=O)[nH]c1=O- InChIKey
QHEMDIZENXAVRQ-UHFFFAOYSA-N- Molecular formula
- C6H9N3O2
- Average molar mass
- 155.15 g/mol
- Monoisotopic mass
- 155.06947654
Names & identifiers
- Preferred name
- 6-Amino-1-ethyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
- IUPAC
- 6-amino-1-ethylpyrimidine-2,4-dione
- English name
- 6-Amino-1-ethyl-1H-pyrimidine-2,4-dione
- Molecular formula
- C6H9N3O2
- Molecular weight
- 155.15
Names & synonyms
Show more names
Database identifiers
- CAS
41862-09-3- PubChem CID
- 853899
- DTXSID
DTXSID70357513- ChEMBL
CHEMBL4095390- EC Number
- 667-716-9
Properties
Computed structural properties
- XLogP
- -0.9
- Topological polar surface area
- 75.4 Ų
- Hydrogen bond donors
- 2
- Hydrogen bond acceptors
- 3
- Rotatable bonds
- 1
- Heavy atoms
- 11
- Formal charge
- 0
- Complexity
- 234
Physicochemical properties
- Melting point
- 282 °C · 282 °C (decomp)
- Density
- 1.261 · 1.261±0.06 g/cm3(Predicted)
- pka
- 9.23 · 9.23±0.40(Predicted)
- Symbol(GHS)
- 7 · GHS07
- Signal word
- Warning
- Hazard statements
- 302 · H302
- Precautionary statements
- 264 · P264-P270-P301+P312-P330-P501
Safety & regulation
GHS classification
GHS Classification
Warning
H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
P264, P270, P301+P317, P330, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 39 reports by companies from 2 notifications to the ECHA C&L Inventory.;Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website.
Hazard information
Safety data
- Signal word
- Warning
- Symbol(GHS)
- GHS07
- Hazard statements
- H302
- Precautionary statements
- P264-P270-P301+P312-P330-P501
Chemistry & industry
Applications
Uses1-Ethyl-6-aminouracil, is an intermediate in the synthesis of a series of new substituted Xanthines which have high affinity and selectivity for the human adenosine A2B receptors, and thus can be used as clinical candidate for chronic inflammatory airway diseases.
Upstream & downstream products
Upstream raw materials
Suppliers30 total
Related reactions
Compound notes
Loading…